Ambu CEO predicts short-term shipping challenges for Core business

Shipment delays of Ambu's Core products won't distract CEO Juan José Gonzalez from focusing on creating sales growth within endoscopy.

Photo: Ambu/PR

On Tuesday evening, Ambu downgraded its financial guidance for organic growth after global shipping delays have affected sales and increased costs of its Core business in the fourth quarter of the year.

However, the CEO at the medtech company Juan José Gonzalez emphasizes that the company regards these issues as short-term, and that the focus on its most important priority hasn't shifted – which is driving growth within the visualization segment, meaning the sales of endoscopes.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs